No Data
No Data
Healthcare Stocks at an 'Inflection Point,' Analyst Says
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by
GoodRx Partners With Boehringer Ingelheim to Discount Humira Biosimilar
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House.Under the Biden
Top PBM Execs to Testify Before House Oversight Committee
We Like These Underlying Return On Capital Trends At Cigna Group (NYSE:CI)
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world, we'd like to see a company investing more capital into its business and ideally